Trinity’s platform delivery technology has been developed over the past ten years at the National Cancer Institute and is covered by broad issued and pending patents. It has been the subject of multiple research articles published in leading peer-reviewed scientific journals.

Trinity has filed numerous patents covering its carrier and specific applications.